Product overview

Name CGP 37157
Purity >99%
Description Potent, selective mitochondria Na+ / Ca2+ exchange inhibitor
Write Your Own Review
You're reviewing:CGP 37157
Rate this item:


CGP 37157 product vial image | Hello Bio

Biological Data

Biological description Potent and selective mitochondria Na+ / Ca2+ exchange inhibitor (IC50 = 0.36 µM). Also inhibits sarco/endoplasmic reticulum Ca2+-stimulated ATPase (SERCA) and activates ryanodine receptor channels (RyRs) (EC50 values are 9.4 and 12.0 µM for cardiac and skeletal RyRs respectively). Displays neuroprotective properties.

Solubility & Handling

Storage instructions Room temperature
Solubility overview Soluble in DMSO (100mM)
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.



More Info


More Info

Chemical Data

Purity >99%
Chemical name 7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2(3H)-one
Molecular Weight 324.22
Chemical structure CGP 37157  [75450-34-9] Chemical Structure
Molecular Formula C15H11Cl2NOS
CAS Number 75450-34-9
PubChem identifier 2688
InChi InChI=1S/C15H11Cl2NOS/c16-9-5-6-13-11(7-9)15(20-8-14(19)18-13)10-3-1-2-4-12(10)17/h1-7,15H,8H2,(H,18,19)
MDL number MFCD09055422

References for CGP 37157

References are publications that support the biological activity of the product
  • CGP37157, an inhibitor of the mitochondrial Na+/Ca2+ exchanger, protects neurons from excitotoxicity by blocking voltage-gated Ca2+ channels.

    Ruiz A et al (2014) Cell Death Dis 5 : e1156.
  • Benzothiazepine CGP37157 and its isosteric 2'-methyl analogue provide neuroprotection and block cell calcium entry.

    González-Lafuente L et al (2012) ACS Chem Neurosci 3(7) : 519-29.
  • CGP-37157 inhibits the sarcoplasmic reticulum Ca?+ ATPase and activates ryanodine receptor channels in striated muscle.

    Neumann JT et al (2011) Mol Pharmacol 79(1) : 141-7.
  • Selectivity of inhibition of Na(+)-Ca2+ exchange of heart mitochondria by benzothiazepine CGP-37157.

    Cox DA et al (1993) J Cardiovasc Pharmacol 21(4) : 595-9.

4 Item(s)